FDA Panel OKs Pfizer Booster Shot for People 65 or Older, But Not Younger
FRIDAY, Sept. 17, 2021 (HealthDay News) — An advisory panel to the U.S. Food and Drug Administration on Friday recommended a third Pfizer-BioNTech COVID vaccine booster shot for all Americans aged 65 or older, as well as for those deemed to be at high risk for severe illness. According toContinue Reading